Masimo Corp (MASI)
160.13
-1.55
(-0.96%)
USD |
NASDAQ |
Nov 14, 16:00
160.13
0.00 (0.00%)
After-Hours: 20:00
Masimo Gross Profit (Annual): 1.004B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.004B |
December 31, 2022 | 1.059B |
December 31, 2021 | 808.40M |
December 31, 2020 | 743.00M |
December 31, 2019 | 629.17M |
December 31, 2018 | 574.89M |
December 31, 2017 | 522.03M |
December 31, 2016 | 478.34M |
December 31, 2015 | 409.98M |
December 31, 2014 | 390.78M |
December 31, 2013 | 358.83M |
Date | Value |
---|---|
December 31, 2012 | 326.25M |
December 31, 2011 | 294.13M |
December 31, 2010 | 285.58M |
December 31, 2009 | 248.80M |
December 31, 2008 | 217.62M |
December 31, 2007 | 182.68M |
December 31, 2006 | 162.70M |
December 31, 2005 | 65.17M |
December 31, 2004 | |
December 31, 2003 | 24.29M |
December 31, 2002 | 20.20M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
629.17M
Minimum
2019
1.059B
Maximum
2022
848.57M
Average
808.40M
Median
2021
Gross Profit (Annual) Benchmarks
Boston Scientific Corp | 9.895B |
Baxter International Inc | 4.975B |
AngioDynamics Inc | 154.70M |
Accuray Inc | 142.92M |
Tandem Diabetes Care Inc | 367.69M |